CRDF
Cardiff Oncology Inc
NASDAQ: CRDF · HEALTHCARE · BIOTECHNOLOGY
$1.73
+6.79% today
Updated 2026-04-30
Market cap
$117.60M
P/E ratio
—
P/S ratio
198.31x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$1 – $5
Volume
0.7M
Cardiff Oncology Inc (CRDF) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+37.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-2.2%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.11 | +41.7% | $1.91 | $1.94 | +1.6% |
| 2025-11-06 | $-0.17 | +19.0% | $2.24 | $2.19 | -2.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.18 | $0.00 | +100.0% | — | — |
| 2025-12-31 | $-0.19 | $-0.11 | +41.7% | $243000.00 | +60.9% |
| 2025-09-30 | $-0.21 | $-0.17 | +19.0% | $120000.00 | -27.3% |
| 2025-06-30 | $-0.19 | $-0.21 | -10.5% | $121000.00 | -25.8% |
| 2025-03-31 | $-0.19 | $-0.20 | -5.3% | $109000.00 | -46.8% |
| 2024-12-31 | $-0.25 | $-0.21 | +15.2% | $151000.00 | -3.2% |
| 2024-09-30 | $-0.27 | $-0.25 | +7.4% | $165000.00 | +17.0% |
| 2024-06-30 | $-0.25 | $-0.26 | -4.0% | $163000.00 | +50.9% |
| 2024-03-31 | $-0.25 | $-0.22 | +12.0% | $205000.00 | — |
| 2023-12-31 | $-0.28 | $-0.21 | +25.0% | $156000.00 | — |
| 2023-09-30 | $-0.28 | $-0.22 | +21.4% | $141000.00 | — |
| 2023-06-30 | $-0.26 | $-0.25 | +3.8% | $108000.00 | — |
Frequently asked questions
Has Cardiff Oncology Inc beaten earnings estimates?
Cardiff Oncology Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +37.5% over the last 4 quarters.
How does CRDF stock react to earnings?
CRDF stock has moved an average of -0.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.